< Back to companies
TCC

TCC

Hamburg, Germany

Our next generation digital telemedicine solutions enhance the quality and efficacy of medical care, allowing the healthcare staff to refocus on its original job – caring for the patient.The Tele-ICU team with one highly experienced intensivist can provide service for 100 or more ICU patients at any time by leveraging high quality telemedicine clinical decision support, made possible by predictive algorithms and artificial intelligence. Machine learning can enable the tele-ICU team to identify patterns in large data sets of high-frequency, real-time patient data (e.g. vital parameters, laboratory results, ventilator setup, etc.) to provide support that can range from detection of unintentional pharmaceutical interactions to prediction of deterioration and outcome of ICU patients.This transformation in ICU care will result in large medical competence centers providing this type of high-end telemedicine and will create new specialties such as “Telemedicine Specialist”.Again, telemedicine is not a competitor, but rather a supporter, of ICU performance optimization. Collaboration between centralized centers and bedside teams will lead to improved outcomes, shorter length of stay, decreased purchased care costs, and greater staff satisfaction.The Society of Critical Care recently recommended replacing the term “tele-ICU” with “tele-critical-care” due to the fact that existing tele-ICU providers have extended their service to other departments (e.g. emergency department, stroke unit), indicating fast adoption of telemedicine in broad applications.Furthermore, many medical smartphone apps exist, though quality and relevance varies greatly. As smartphones permeate modern daily life and routine, there is growing interest in utilizing them in telemedicine; however, at this point there is limited large-scale evaluation of this use.

Share
Shareable draft
Get Involved in TCC

Company Info

Founded
2020
Website
tcc-clinicalsolutions.de/
Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of TCC?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in TCC
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free